NCT07147972View on ClinicalTrials.gov

Comparative Study of Nutraceuticals vs. Conventional Prophylactic Therapy in the Management of Migraine

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 20, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2026

Conditions

MigraineNutraceuticals

Interventions

DRUG

Propranolol 80 mg

Propranolol 40-80 mg/day

DRUG

Magnesium 400Mg

Magnesium 400 mg daily

All Listed Sponsors

lead

Fayoum University

OTHER